Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Kangsters Unveils Revolutionary Treadmills at Rollettes Experience 2024: Celebrating Innovation and Empowerment 2024-07-11 00:00
WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year 2024-07-10 13:30
KOSÉ, I Peace, and Reju Enter Strategic Partnership to Develop Personalized Beauty Products Based on iPS Cells 2024-07-09 23:00
Alteogen Receives Ministry of Food and Drug Safety (MFDS) Approval for Tergase® 2024-07-08 21:00
Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors 2024-07-08 16:28
Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast Cancer (TNBC) 2024-07-05 21:00
IASO Bio and Innovent Enhance Strategic Collaboration in Cell Therapy 2024-07-05 16:30
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis 2024-07-05 16:07
Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia 2024-07-05 15:56
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus 2024-07-04 11:17
Bloomage Ranks on World Brand Lab's China 500 Most Valuable Brands List 2024-07-02 21:00
PharmAbcine's Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg 2024-07-02 11:02
Altos Biologics Files for Approval of Aflibercept Biosimilar 2024-07-02 08:00
IASO Bio Presented Clinical Data and Single-cell Analysis of Equecabtagene Autoleucel for the Treatment of Central Nervous System Autoimmunity in Oral Presentation at EAN Congress 2024 2024-07-01 15:43
Comprehensively Covering Multiple Myeloma: IASO Bio's GPRC5D CAR-T Product RD118 Receives IND Approval from NMPA 2024-06-28 18:59
Natalia Vodianova Invests in Swiss Beauty and Longevity Brand NIANCE 2024-06-28 11:59
bioSeedin Expanded Global Licensing and Partnership Opportunities at 2024 BIO International Convention 2024-06-26 21:00
Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau 2024-06-26 20:56
Hyundai Bioscience succeeds in developing 'Multi-treatment for mosquito-borne viral infections' including Dengue Fever 2024-06-26 09:17
Porton Advanced introduces the MaxCyte ExPERT GTx Flow Electroporation instrument, continuing to provide customers with end-to-end cell and gene therapy CRO & CDMO services 2024-06-25 20:00
1 12 13 14 15 16 222